In a large clinical trial, the drug, called Nexavar, extended the lives of patients by almost three months, or 35 percent. While that is far from a cure, experts say it represents a breakthrough after years of efforts to find a drug that works.
read more at http://www.nytimes.com/2007/06/04/health/04liver.html
Tuesday, 8 April 2008
Nexavar
Labels:
liver cancer